Cargando…
Diuretics in the management of chronic heart failure: when and how
Heart failure is an increasingly prevalent condition resulting in recurrent hospitalisations and significant mortality and morbidity. The management of heart failure has evolved, and multiple drugs have an established mortality benefit in heart failure with reduced ejection fraction. Although the fo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722345/ https://www.ncbi.nlm.nih.gov/pubmed/36479331 http://dx.doi.org/10.18773/austprescr.2022.069 |
_version_ | 1784843953246306304 |
---|---|
author | Magdy, Joseph S McVeigh, James Indraratna, Praveen |
author_facet | Magdy, Joseph S McVeigh, James Indraratna, Praveen |
author_sort | Magdy, Joseph S |
collection | PubMed |
description | Heart failure is an increasingly prevalent condition resulting in recurrent hospitalisations and significant mortality and morbidity. The management of heart failure has evolved, and multiple drugs have an established mortality benefit in heart failure with reduced ejection fraction. Although the focus should be on ensuring that patients are treated with the maximum tolerated doses of these guideline-directed therapies, diuretics continue to play a key role in the management of clinical congestion in all forms of heart failure. Clinicians play a key role in heart failure management. Familiarity with the role of diuretics and their dosing and monitoring is critical. |
format | Online Article Text |
id | pubmed-9722345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-97223452022-12-06 Diuretics in the management of chronic heart failure: when and how Magdy, Joseph S McVeigh, James Indraratna, Praveen Aust Prescr Article Heart failure is an increasingly prevalent condition resulting in recurrent hospitalisations and significant mortality and morbidity. The management of heart failure has evolved, and multiple drugs have an established mortality benefit in heart failure with reduced ejection fraction. Although the focus should be on ensuring that patients are treated with the maximum tolerated doses of these guideline-directed therapies, diuretics continue to play a key role in the management of clinical congestion in all forms of heart failure. Clinicians play a key role in heart failure management. Familiarity with the role of diuretics and their dosing and monitoring is critical. NPS MedicineWise 2022-11-30 2022-12 /pmc/articles/PMC9722345/ /pubmed/36479331 http://dx.doi.org/10.18773/austprescr.2022.069 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Article Magdy, Joseph S McVeigh, James Indraratna, Praveen Diuretics in the management of chronic heart failure: when and how |
title | Diuretics in the management of chronic heart failure: when and how |
title_full | Diuretics in the management of chronic heart failure: when and how |
title_fullStr | Diuretics in the management of chronic heart failure: when and how |
title_full_unstemmed | Diuretics in the management of chronic heart failure: when and how |
title_short | Diuretics in the management of chronic heart failure: when and how |
title_sort | diuretics in the management of chronic heart failure: when and how |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722345/ https://www.ncbi.nlm.nih.gov/pubmed/36479331 http://dx.doi.org/10.18773/austprescr.2022.069 |
work_keys_str_mv | AT magdyjosephs diureticsinthemanagementofchronicheartfailurewhenandhow AT mcveighjames diureticsinthemanagementofchronicheartfailurewhenandhow AT indraratnapraveen diureticsinthemanagementofchronicheartfailurewhenandhow |